NSAID Dolobid inhibited familial amyloid polyneuropathy progression
(dailyRx News) Familial amyloid polyneuropathy is a very rare condition. New research shows that a relatively common medication may slow progression of the disease.
Researchers tested diflunisal (brand name Dolobid) on patients with familial amyloid polyneuropathy in a two-year trial. These researchers found that patients taking the medication experienced slowed progression of this nervous system disease. The authors of this study suggested that the medication may provide a lower cost treatment option for people with the rare condition.Read more from RxWiki HERE.